RE:RE:RE:So we have another webinar…Yea basically...I think both companies are after the same market with similar technologies..i like to believe that pats performs better but I don't actually know that..even if pat does have a slight edge from a performance perspective...they pretty much have the same limitations i.e., needs to be used in low cluttered environments. With evolv having so much more money and brand awareness I personally think the best way for pat to differentiate itself from evolv is to dev a product that can perform well in a high cluttered environment. But the good news is this should be ready for prime time soon. At least that was my understanding based on the corp presentations. There may be other ways to get these sales but thats how I believe would be the easiest and highest probability of success..but what do I know? I'm a retail investor of an otc stock that has performed terribly for years
all imo long pat